Fischer Medical Ventures Ltd has informed the exchange on intimation of receipt annual secretarial compliance report for the year ended 31.03.2025
FISCHER · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fischer Medical Ventures Ltd has submitted its Annual Secretarial Compliance Report for the financial year ended 31 March 2025, as required under Regulation 24A of SEBI's Listing Regulations. The report was issued by Practising Company Secretary M/s. Nuren Lodaya and Associates on 30 May 2025. The company is broadly compliant across all key areas — including secretarial standards, board policies, website disclosures, insider trading rules, related party transactions, and no action by SEBI or stock exchanges. A few minor issues were flagged: the company filed Form FC-GPR with RBI after a delay (paying late fees), withdrew a preferential share allotment that had been approved in the September 2024 AGM via an EGM in January 2025, and had a previous-year instance of a 13-day delay in reclassification of promoter/public status. Management says it has strengthened internal compliance controls to avoid such lapses going forward.
This is a routine annual compliance filing with no material adverse findings, so it is unlikely to move the stock. The withdrawal of the preferential share issue removes a potential dilution overhang but also signals that the previously planned capital raise did not go through.